FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--ReGen Biologics, Inc. (OTC BB: RGBI) an innovative orthopedic products company announced today that it has completed a $6.95 million private equity placement.
Commenting on the financing, Gerald E. Bisbee, Jr., Ph.D., Chairman and Chief Executive Officer stated, “We are delighted with the participation of existing investors from the U.S. and Europe and we welcome new investors to this financing.”
